tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Ryskin, 48 are a HOLD (36.36%), 67 are a BUY (50.76%), 17 are a SELL (12.88%).
Analyst Michael Ryskin, currently employed at BAML, carries an average stock price target met ratio of 68.25% that have a potential upside of 17.31% achieved within 155 days.
Michael Ryskin’s has documented 258 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ICLR, ICON PLC.
Analyst best performing recommendations are on OMIC (SINGULAR GENOMICS SYSTEMS).
The best stock recommendation documented was for OMIC (SINGULAR GENOMICS SYSTEMS) at 6/21/2021. The price target of $780 was fulfilled within 3 days with a profit of $85.2 (12.26%) receiving and performance score of 40.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jan-2025
$11
$0.84 (8.27%)
$11
17 days ago
(23-Sep-2026)
13/13 (100%)
$1.25 (12.82%)
216
Buy Since 28-May-2026
$16
$5.84 (57.48%)
$13
1 months 2 days ago
(08-Sep-2026)
1/4 (25%)
$7.09 (79.57%)
27
Buy Since 08-May-2026
$17
$6.84 (67.32%)
$11
3 months 8 days ago
(02-Jul-2026)
1/2 (50%)
$5.38 (46.30%)
52
Buy Since 04-May-2023
$16
$5.11 (46.92%)
3 months 15 days ago
(25-Jun-2026)
14/15 (93.33%)
$5.79 (56.71%)
444
Hold Since 25-Mar-2026
$10
$-0.16 (-1.57%)
$4.1
3 months 15 days ago
(25-Jun-2026)
2/3 (66.67%)
$-0.21 (-2.06%)
27
Which stock is Michael Ryskin most bullish on?
Which stock is Michael Ryskin most reserved on?
What Year was the first public recommendation made by Michael Ryskin?
